Want to join the conversation?
$BCR's 3Q15 Surgical Specialties sales increased 3% YoverY to $139.8MM. U.S. sales increased 6%, while international sales grew 4%. Bio-surgery business grew in double-digit in the quarter. Soft tissue repair business grew 7% with its synthetic hernia products sales growing 6%.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.